Baillie Gifford & Co

Q3 2022 13F Holdings Report, Stock Holdings

Signature - Title
Grant Meikle - Compliance Manager
Location
Edinburgh
Holdings as of
September 30, 2022
Value $
$97B
Num holdings
475
Date filed
10/27/2022, 06:35 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included TSLA, MRNA, MELI, AMZN, and ILMN.
Previous filing
Q2 2022 - Aug 8, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q3 compared to 2022 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Grant Meikle Compliance Manager Edinburgh, United Kingdom 10/27/2022

Other Included Managers (4):

Num Name Location File Number
1 Baillie Gifford & Co Ltd Edinburgh, United Kingdom 028-04841
2 Baillie Gifford Overseas Ltd Edinburgh, United Kingdom 028-04395
3 Baillie Gifford Investment Management (Europe) Ltd Dublin, Ireland 028-19482
4 Baillie Gifford International LLC Edinburgh, United Kingdom 028-20241